Participatory research for the development of information, education and communication tools to promote intermittent preventive treatment of malaria in pregnancy in the Democratic Republic of the Congo, Nigeria and Mozambique

BACKGROUND: To improve the coverage of intermittent preventive treatment of malaria in pregnancy (IPTp) in Africa, Medicines for Malaria Venture (MMV) developed, tested and validated a new packaging of sulfadoxine–pyrimethamine (SP), as well as specific communications tools designed to improve knowl...

Descripción completa

Detalles Bibliográficos
Autores principales: Faye, Sylvain Landry Birane, Lugand, Maud Majeres
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8136127/
https://www.ncbi.nlm.nih.gov/pubmed/34011371
http://dx.doi.org/10.1186/s12936-021-03765-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8136127/
https://www.ncbi.nlm.nih.gov/pubmed/34011371
http://dx.doi.org/10.1186/s12936-021-03765-4

Ejemplares similares